How Chipiron’s rethinking the future of MRI

The landscape of medical device funding is experiencing a resurgence, reminiscent of the boom seen in 2021, with billions being invested in the fields of diagnostics and imaging. Despite this wave of financial support, a longstanding issue persists: the exorbitant costs of essential medical equipment, such as MRI machines, which can run into the millions and are primarily accessible through large hospitals. Evan Kervella, the founder and CEO of the Paris-based startup Chipiron, is on a mission to address this challenge. During a recent discussion on the Equity podcast, he elaborated on his innovative approach to democratizing access to MRI technology, aiming to make it available beyond traditional hospital settings. Kervella's vision represents a significant shift in how critical medical technology can be utilized, and he shared insights into the obstacles his startup faces and the potential impact of their solutions. For those interested in the future of medical imaging and diagnostics, this conversation offers a glimpse into the possibilities that lie ahead. Stay tuned for more updates, as Equity will return with its weekly news roundup, featuring the latest developments in technology and innovation. The Equity podcast, a flagship series from TechCrunch, is produced by Theresa Loconsolo and airs every Wednesday and Friday. You can subscribe on platforms like Apple Podcasts, Overcast, and Spotify, and follow Equity on X and Threads at @EquityPod.